Skip to main content
Download PDF

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda

Malaria Journal volume 21, Article number: 37 (2022) Cite this article

The Original Article was published on 24 December 2021

Correction to: Malaria Journal (2021) 20:484 https://doi.org/10.1186/s12936-021-04021-5

Following publication of the original article [1], it was brought to the publisher’s attention that incorrect details had been provided in the trial registration information of the article.

Where it should read:

  • Trial registration: The trial was also registered with the Pan African Clinical Trial Registry (https://pactr.samrc.ac.za/) with study Trial No. PACTR201811640750761.

It said:

  • Trial registration: The trial was also registered with the ISRCTN registry with study Trial No. PACTR201811640750761.

The original article has been updated accordingly.

Reference

  1. Ebong C, Sserwanga A, Namuganga JF, Kapisi J, Mpimbaza A, Gonahasa S, Asua V, Gudoi S, Kigozi R, Tibenderana J, Bwanika JB, Bosco A, Rubahika D, Kyabayinze D, Opigo J, Rutazana D, Sebikaari G, Belay K, Niang M, Halsey ES, Moriarty LF, Lucchi NW, Svigel Souza SS, Nsobya SL, Kamya MR, Yeka A. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar J. 2021;20:484. https://doi.org/10.1186/s12936-021-04021-5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Diseases Research Collaboration, Kampala, Uganda

    Chris Ebong, Asadu Sserwanga, Jane Frances Namuganga, James Kapisi, Arthur Mpimbaza, Samuel Gonahasa, Victor Asua, Sam L. Nsobya, Moses R. Kamya & Adoke Yeka

  2. USAID’s Malaria Action Program for Districts, Kampala, Uganda

    Sam Gudoi, Ruth Kigozi, James Tibenderana & John Bosco Bwanika

  3. National Malaria Control Division, Ministry of Health Uganda, Kampala, Uganda

    Agaba Bosco, Denis Rubahika, Daniel Kyabayinze, Jimmy Opigo & Damian Rutazana

  4. U.S. President’s Malaria Initiative, Kampala, Uganda

    Gloria Sebikaari, Kassahun Belay & Mame Niang

  5. Malaria Branch, Centers for Disease Control and Prevention & President’s Malaria Initiative, Atlanta, GA, USA

    Eric S. Halsey, Leah F. Moriarty, Naomi W. Lucchi & Samaly S. Svigel Souza

  6. Makerere University College of Health Sciences, Kampala, Uganda

    Sam L. Nsobya, Moses R. Kamya & Adoke Yeka

Authors
  1. Chris Ebong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asadu Sserwanga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jane Frances Namuganga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Kapisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arthur Mpimbaza
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samuel Gonahasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Victor Asua
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sam Gudoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ruth Kigozi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. James Tibenderana
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John Bosco Bwanika
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Agaba Bosco
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Denis Rubahika
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Daniel Kyabayinze
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jimmy Opigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Damian Rutazana
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Gloria Sebikaari
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Kassahun Belay
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Mame Niang
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Eric S. Halsey
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Leah F. Moriarty
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Naomi W. Lucchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Samaly S. Svigel Souza
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Sam L. Nsobya
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Moses R. Kamya
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Adoke Yeka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris Ebong.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ebong, C., Sserwanga, A., Namuganga, J.F. et al. Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar J 21, 37 (2022). https://doi.org/10.1186/s12936-022-04049-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12936-022-04049-1

Malaria Journal

ISSN: 1475-2875

Contact us